CW Insider, May 18

Dow Chemical chairman and CEO Andrew Liveris defended the company’s acquisition of Rohm and Haas at Dow’s annual meeting last week, noting that allowing a competitor to acquire the company would have had a “profound and negative effect” on Dow.   In Geneva, chemical makers faced criticism that industry is failing to provide sufficient funding for Strategic Approach of International Chemicals Management at the United Nations (UN) International Conference on Chemicals Management.   Other articles of interest can be found at...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers